← Back to Search

CHAMindWell for Depression

N/A
Waitlist Available
Led By Zev Schuman-Olivier, MD
Research Sponsored by Cambridge Health Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial is testing three different approaches to improving mental health during the COVID-19 pandemic. The first is a mindfulness-based intervention, the second is internet-based cognitive behavioral therapy, and the third is a remote monitoring and telephone coaching program. The trial will last for 24 weeks and will measure depressive symptoms, alcohol and drug use, stress-related affect reactivity, and salivary inflammatory markers.

Eligible Conditions
  • Depression
  • Stress
  • Anxiety
  • Substance Abuse
  • Alcohol Use Disorder
  • Substance Use
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening, baseline, weeks 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 20, 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening, baseline, weeks 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 20, 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression Severity (CAT-DI)
Secondary outcome measures
Drug Use Rates
Heavy Drinking Days
Televisits (AKA Mental Wellness Assessments)
Other outcome measures
Adverse Event Patient Participant Self-Report Form
Beck Depression Inventory (BDI-II)
Brief Experiential Avoidance Questionnaire (BEAQ)
+16 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MBCT-R + CHA-MWExperimental Treatment2 Interventions
Mindfulness-Based Cognitive Therapy (MBCT) is an effective group intervention for depression and anxiety that combines mindfulness training with elements of cognitive therapy. This will be delivered with CHAMindWell mental wellness monitoring with CAT-MH and telephone coaching as needed.
Group II: iCBT (MoodGym) + CHA-MWActive Control2 Interventions
MoodGym is a form of iCBT, which an evidence-based online program for depression, anxiety, stress and general psychological well-being. This will be delivered with CHAMindWell mental wellness monitoring with CAT-MH and telephone coaching as needed.
Group III: CHA-MWActive Control1 Intervention
Participants randomized to the CHA-MW arm will only receive CHAMindWell mental wellness monitoring with CAT-MH and telephone coaching as needed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell
2021
N/A
~120
CHAMindWell
2021
N/A
~120

Find a Location

Who is running the clinical trial?

Cambridge Health AllianceLead Sponsor
57 Previous Clinical Trials
20,439 Total Patients Enrolled
14 Trials studying Depression
1,028 Patients Enrolled for Depression
National Center for Complementary and Integrative Health (NCCIH)NIH
833 Previous Clinical Trials
669,340 Total Patients Enrolled
61 Trials studying Depression
32,797 Patients Enrolled for Depression
Penn State UniversityOTHER
355 Previous Clinical Trials
125,644 Total Patients Enrolled
13 Trials studying Depression
1,771 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use
2021. "Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04595084.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top